4.6 Article

A Novel RNA Synthesis Inhibitor, STK160830, Has Negligible DNA-Intercalating Activity for Triggering A p53 Response, and Can Inhibit p53-Dependent Apoptosis

期刊

LIFE-BASEL
卷 11, 期 10, 页码 -

出版社

MDPI
DOI: 10.3390/life11101087

关键词

p53; RNA synthesis inhibitor; DNA intercalator; apoptosis

资金

  1. Platform Project for Supporting Drug Discovery and Life Science Research from AMED [JP20am0101086, 1030]
  2. Center for Therapeutic Innovation, Graduate School of Biomedical Sciences, Nagasaki University
  3. Support Center for Advanced Medical Sciences, Tokushima University Graduate School of Biomedical Sciences

向作者/读者索取更多资源

The study found that STK160830 has anti-apoptotic effects on irradiated cells, which are p53-dependent. STK160830 inhibits cell death by reducing the expression of multiple proteins and decreasing mRNA expression. Unlike other RNA synthesis inhibitors, STK160830 does not induce p53 accumulation and shows weak DNA-intercalating activity.
RNA synthesis inhibitors and protein synthesis inhibitors are useful for investigating whether biological events with unknown mechanisms require transcription or translation; however, the dependence of RNA synthesis has been difficult to verify because many RNA synthesis inhibitors cause adverse events that trigger a p53 response. In this study, we screened a library containing 9600 core compounds and obtained STK160830 that shows anti-apoptotic effects in irradiated wild-type-p53-bearing human T-cell leukemia MOLT-4 cells and murine thymocytes. In many of the p53-impaired cells and p53-knockdown cells tested, STK160830 did not show a remarkable anti-apoptotic effect, suggesting that the anti-apoptotic activity is p53-dependent. In the expression analysis of p53, p53-target gene products, and reference proteins by immunoblotting, STK160830 down-regulated the expression of many of the proteins examined, and the downregulation correlated strongly with its inhibitory effect on cell death. mRNA expression analyses by qPCR and nascent RNA capture kit revealed that STK160830 showed a decreased mRNA expression, which was similar to that induced by the RNA synthesis inhibitor actinomycin D but differed to some extent. Furthermore, unlike other RNA synthesis inhibitors such as actinomycin D, p53 accumulation by STK160830 alone was negligible, and a DNA melting-curve analysis showed very weak DNA-intercalating activity, indicating that STK160830 is a useful inhibitor for RNA synthesis without triggering p53-mediated damage responses.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据